167 related articles for article (PubMed ID: 11221715)
1. Pharmacogenomics.
Nat Biotechnol; 2000 Oct; 18 Suppl():IT40-2. PubMed ID: 11221715
[No Abstract] [Full Text] [Related]
2. Genomas: battling side effects with physiotypes.
McDonald J
Yale J Biol Med; 2007 Dec; 80(4):187-90. PubMed ID: 18449393
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics: the implementation phase.
Sadee W
AAPS PharmSci; 2002; 4(2):E5. PubMed ID: 12141268
[TBL] [Abstract][Full Text] [Related]
4. Bridging the knowledge gaps in vaccine design.
Rappuoli R
Nat Biotechnol; 2007 Dec; 25(12):1361-6. PubMed ID: 18066025
[No Abstract] [Full Text] [Related]
5. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
6. Biotech industry tries to recover from 2-year lull.
Brower V
J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
[No Abstract] [Full Text] [Related]
7. 454 life sciences: illuminating the future of genome sequencing and personalized medicine.
Patrick K
Yale J Biol Med; 2007 Dec; 80(4):191-4. PubMed ID: 18449390
[No Abstract] [Full Text] [Related]
8. Drug discovery and development in the age of molecular medicine.
Vallance P; Levick M
Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
[TBL] [Abstract][Full Text] [Related]
9. Genset-Abbott deal heralds pharmacogenomics era.
Marshall A
Nat Biotechnol; 1997 Sep; 15(9):829-30. PubMed ID: 9306389
[No Abstract] [Full Text] [Related]
10. Pharmacogenomics and diagnostics.
Persidis A
Nat Biotechnol; 1998 Aug; 16(8):791-2. PubMed ID: 9702782
[No Abstract] [Full Text] [Related]
11. Biotech drugs come of age; policymakers take notice.
Iglehart JK
Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
[No Abstract] [Full Text] [Related]
12. Arnold Demain.
Demain A
Nat Biotechnol; 2011 Mar; 29(3):193. PubMed ID: 21390012
[No Abstract] [Full Text] [Related]
13. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
14. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
15. Charting the biologic frontier. Interview by Val J. Halamandaris.
Venter C
Caring; 2003 Apr; 22(4):32-40. PubMed ID: 12722564
[No Abstract] [Full Text] [Related]
16. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
17. China's biotech is starting to bloom.
Stipp D
Fortune; 2002 Sep; 146(4):126-30, 132, 134. PubMed ID: 12195673
[No Abstract] [Full Text] [Related]
18. R&D deals boom in 2004.
Lawrence S
Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
[No Abstract] [Full Text] [Related]
19. Microarray technology: an array of opportunities.
Gershon D
Nature; 2002 Apr; 416(6883):885-91. PubMed ID: 11976691
[No Abstract] [Full Text] [Related]
20. Pharmacogenomics: bench to bedside.
Weinshilboum R; Wang L
Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
